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ABSTRACT 
 
MobiHealth aims at introducing new mobile value-
added services in the area of healthcare, based on 2.5 
(GPRS) and 3G (UMTS) technologies, thus promoting 
the use and deployment of GPRS and UMTS. This will 
be achieved by the integration of sensors and actuators 
to a Wireless Body Area Network (BAN). These 
sensors and actuators will continuously measure and 
transmit vital constants along with audio and video to 
health service providers and brokers, improving on one 
side the life of patients and allowing on the other side 
the introduction of new value-added services in the 
areas of disease prevention and diagnostic, remote 
assistance, para-health services, physical state 
monitoring (sports) and even clinical research. 
Furthermore, the MobiHealth BAN system will support 
the fast and reliable application of remote assistance in 
case of accidents by allowing the paramedics to send 
reliable vital constants data as well as audio and video 
directly from the accident site. 
 
I. INTRODUCTION 
 
A. Overall Objective 
 
The MobiHealth project addresses the problem of 
testing the 2.5 and 3G markets by developing and trial 
new value-added services and applications in the area of 
mobile healthcare. On the one hand, 2.5 G networks are 
today under-used due to the lack of innovative services 
[1]. As a result, the deployment of 3G technologies risks 
being delayed and the advances and momentum gained 
in Europe in mobile services during the last few years is 
in danger of being lost. On the other hand, the health 
sector faces serious and increasing problems in the 
management of resources for disease prevention, 
follow-up and remote assistance of patients. The cost of 
in-patient care is increasingly creating problems for 
both, patients and social security organizations [2]. In 
contrast, the market for para-health services and 
applications, such as physical state monitoring during 
sports training and the use of health call centers, is 
becoming increasingly common and available to every 
citizen. Finally, citizen mobility at a pan-European level 
is increasing, with thousands of citizens crossing 
European country borders daily for purposes of 
entertainment, leisure, shopping and business. Thus, the 
introduction of new pan-European mobile health and 
para-health personalized services, based on 2.5 and 3G 
technologies will provide new markets and 
opportunities allowing both, citizens and the industry to 
profit. 
MobiHealth is opening up new application areas for 2.5 
and 3G communication technologies, providing the 
possibility for key-actors (ranging from operators and 
Small/Medium Size Enterprises (SMEs) to service 
providers and hospitals) to gain experience with new 
mobile value-added services. MobiHealth aspires to 
create market demand for the new mobile health value-
added services and applications, thus boosting the 
development, deployment and use of 2.5 and 3G 
communications. 
 
B. Related Projects 
 
MobiHealth builds on the results of past and current 
projects by applying the novel concept of the Body Area 
Network (BAN) as a generic organising concept for the 
disparate elements of m-health systems for patients and 
healthcare professionals. This is a key distinguishing 
feature of MobiHealth. The MobiHealth BAN enables 
not only homecare for patients, but also continuity of 
care in the context of global roaming for the patient / 
citizen. Most important, the MobiHealth BAN concept 
provides a generic platform for implementation and 
bringing to market of a multitude of services, thus 
acting as a service integration technology.  
Notable IST e-health projects related to  MobiHealth 
include AMON and HEALTHMATE. AMON 
(Advanced care and alert portable telemedical monitor) 
[3] targets research, development and validation of a 
wearable personal health system to monitor and 
evaluate human vital signs using advanced bio-sensors, 
plus analysis and transmission of vital signs to a remote 
telemedicine center via GSM/UMTS. HEALTHMATE 
(Personal intelligent health mobile systems for telecare 
and tele-consultation) [4] targets the development of 
portable personal systems for health telecare and tele-
consultation based on GPRS/UMTS. 
MobiHealth complements these two projects since it 
targets not the development of the monitoring devices, 
but the introduction of a complete m-health service and 
a set of large scale trials.  
Other related IST projects include @HOME (Remote 
home monitoring of patients)  project [5], which targets 
next generation health services using UMTS, Bluetooth 
and ubiquitous medical sensors for patient monitoring in 
the recovery phase and for chronically ill patients, also 
addressing patient compliance., 
TELEMEDICARE (Telematic support for patient 
focused distant care) [6], CHRONIC (An information 
capture and processing environment for chronic patients 
in the information society) [7], MOBI-DEV (Mobile 
devices for healthcare applications), MOEBIUS (Mobile 
extranet based integrated user services) [8] and M2DM 
(Multi-access services for telematic management of 
Diabetes Mellitus) [9].MobiHealth will build upon the 
results of these projects extending their concepts and 
offering direct links to health centers, transforming them 
into real services, and offering a platform that will act as 
the integrator for new business applications. 
 
II. PROJECT APPROACH 
 
The overall objective of the project is the introduction 
of new mobile health services, based on the on-line, 
continuous monitoring of vital signs, via GPRS and 
UMTS technologies. These services will be supported 
by the MobiHealth Body Area Network (BAN), a 
wireless system that will allow the simple connection of 
different vital signal sensors. The BAN, the 
GPRS/UMTS infrastructures, as well as the new 
services will be tested via a set of trials that will be 
conducted in different European countries. 
The main thrust of the MobiHealth project is to conduct 
trials that introduce new services by providing 
continuous medical care (in-home and out-of-home), 
preferably based on wireless sensors and actuators 
(ranging from vital constants sensors to audio/video 
streams), integrated into Body Area Networks 
communicating with different health brokers via GPRS 
and UMTS connections. The MobiHealth BAN will be 
sufficiently generic to enable the seamless integration 
(wear and use) of different sensors and actuators. This 
way, different kinds of services relating to continuous 
health monitoring can be introduced, including various 
forms of home care, physical status monitoring during 
sports, patient follow-up, medical testing, etc. 
The MobiHealth project will first concentrate on the 
integration of existing and experimental prototype 
hardware components in the generic BAN platform. For 
this, existing and experimental 2.5 – 3G capable 
hardware components and prototypes (such as the 
Compaq iPAQ, or the forthcoming, fully programmable 
Ericsson mobile phone) will be used, to which a specific 
set of commercially available sensors and actuators will 
be integrated by adapting and extending them with 
wireless connectivity. Next, a series of test scenarios 
and evaluation methodologies will be developed, 
introducing the new, mobile health services.  
The result of the project will be a set of large scale 
trials, providing the context in which the business 
perspectives of the new mobile health services can be 
evaluated, demonstrating the feasibility of the 
applications, its usefulness and testing the 
interoperability of the 2.5/3G network infrastructures in 
different countries. The aim is in the design of new 
value-added services for the well-being of the citizens 
and the creation of a standard that is acceptable by the 
major players. 
Since health related data and information is highly 
protected by law and by professional ethics. the 
MobiHealth project will take all reasonable measures to 
protect information relating to patients and users. To 
this end, security and encryption technologies will be 
used in the data transmission; at the receiving site, only 
authorized personnel working for the project will be 
able to access the data etc. If needed, confidentiality and 
responsibility discharge documents will be signed with 
the users. In this context MobiHealth aims at defining a 
harmonized protection framework, based on EU 
reference directives [10]. 
Upon completion of the project, several technological, 
economic and methodological results are expected. A 
firstresult will be the integration of a generic m-health 
BAN, equipped with a basic set of sensors/actuators. A 
first version of a BAN will be implemented by 
integrating existing technologies. The BAN will have a 
central unit (MBU) that will serve as the 
communications gateway to the public GPRS and 
experimental UMTS networks and it will implement a 
part of the application functionalities. The generic BAN 
will allow the simple introduction of new sensors, 
allowing a high degree of personalization and 
customization. 
A second resultwill be  the development of new m-
health services and methodologies for their trial and 
evaluation. The new services will allow patients to be 
continuously monitored by a remote health center.  
A third result will be the verification of the suitability of 
GPRS and UMTS networks for m-health applications. 
Different issues will be tested and validated, ranging 
from security aspects to ease of usage and to quality of 
service. 
Of major importance to the project is the dissemination 
of the results to a large public. The project results will 
be presented in expositions, announced in the public 
media and introduced to consortium customers. It is 
expected, that by the end of the project, the new 
possibilities offered by the MobiHealth technologies, 
will be well understood and appreciated by both, the 
public and commercial companies. 
 
 
III. PROJECT IMPLEMENTATION 
 
A. Functional Description 
 
The MobiHealth trials will implement simple, but 
complete services that can be immediately deployed 
over the UMTS and GPRS networks. The MobiHealth 
patient/user will be equipped with different 
interoperating or independent vital constant sensors, 
ranging from blood pressure and pulse rate, to blood 
glucose and cholesterol sensors, to electrocardiograms 
and even brain activity sensors, and from different 
actuators, such as insulin or morphine pumps, to pace 
maker controllers and even electrical muscle 
stimulation. Audio and video I/O devices may also be 
incorporated in the BAN, depending on the needs of the 
application. The vital constant measurements will then 
be sent to a health broker (which may be a hospital or a 
medical call center), where specialists will be able to 
observe the evolution of the patient and intervene when 
needed. The communication will be based on 2.5 – 3G 
wireless technologies so that the patient/user has 
complete freedom of movement and can pursue a 
normal life despite of the need for continuous 
monitoring. Depending on the patient and the treatment, 
feedback might be sent to the sensors/actuators (e.g. 
instructions to increase the sampling frequency, insulin 
pump control, pace maker tuning, etc.), or directly to the 
patient in the form of audible or visual signals. The 
MobiHealth BAN will handle transmission details and 
problems such as network disconnection (e.g. when 
entering a tunnel) and quality of service adaptation due 
to hand-over situations. 
The MobiHealth BAN can also be deployed at the scene 
of an accident or disaster. The paramedic on the scene 
of the accident will be equipped with a BAN with video 
and audio equipment and will be able to attach and 
connect BAN sensors to the victim and thus transmit 
vital constants to the hospital along with visual and 
audio information. This way the accident site is 
transformed into an emergency room where the 
(telepresent) specialists can intervene from the hospital. 
The BAN technology, together with the 2.5 – 3G 
technology, will thus enable virtual trauma teams to be 
rapidly assembled in response to an emergency 
situation. 
The use of GPRS and UMTS as communication 
technology is essential due to the need to support a 
continuous connection to the healthcare center, the high 
bandwidth required for the transmission of the data 
(which can easily reach the level of 100 Kbps), the 
communication costs involved (in GPRS and UMTS, 
the cost is calculated per Kb, instead of per minute of 
connection) and the high quality of service required for 
all health related applications. These are requirements 
which cannot be met with current GSM technology.  
 
B. Implementation Plan 
 
The MobiHealth Body Area Network (BAN) will be 
connected to the public GPRS and experimental UMTS 
networks. The BAN will be based on existing 
technology, which will be adapted according to the 
MobiHealth application needs. In a first step, a set of 
sensors will be extended with wireless intra-BAN 
communication capabilities. Different options will be 
evaluated, ranging from Bluetooth [12] to ZigBee [11]. 
Each sensor sends its signals to the MBU, and actuators 
receive control signals from the MBU. The MBU 
operates in different modes. The first mode is a “store 
mode” (store data for certain periods and send them in 
regular intervals to the hospital). The second mode is 
the “process mode” (process the data and provide the 
patient with some first level information). The third 
mode is the “stream mode” (establish a permanent 
connection to the hospital and send the data in a 
continuous stream). 
 In parallel, depending on the conceptual and functional 
definitions of services at the beginning of the project, 
the generic BAN will start to be developed. This will 
include the programming of the MBU, which will be 
equipped with GPRS and/or UMTS communication 
capabilities. Candidate platforms are the Compaq iPAQ 
and the next generation, fully programmable 3G 
wireless mobile phone from Ericsson. Depending on the 
services and applications that will be trialed, either one 
or both devices will be used in the project.  The generic 
BAN will provide functionality for plug and play sensor 
connectivity, will handle all issues related to security, 
quality of service control, hand-over, etc. 
 
C. Project Trial Scenarios 
 
As mentioned before, the MobiHealth project will 
realize and trial a small set of applications, built on top 
Mobile Health BAN structure
of the generic BAN platform. The choice of the trial 
applications will be done in the first months of the 
project, depending on market interest and business 
potential. The project will set up two general trials, one 
over GPRS and one over UMTS. Different scenarios 
with different requirements will be trialed for each 
communication infrastructure. The trials will involve a 
sufficiently large number of users, so that credible 
results can be drawn. For the GPRS trials, the existing 
publicly available infrastructures will be used, for 
UMTS, experimental testbeds will be used. 
The trial scenarios will be based on rigorous scientific 
criteria, so that both, medical and technical results are 
reliable. A total of four trial sites will be set up in 
different countries, involving different health centers 
(The Netherlands, Sweden, Germany, Spain). 
There are a few potential trial scenarios. A first scenario 
concerns “Prevention of exacerbation in chronic 
patients”: here, the main purpose is to evaluate the 
benefits of distant patient monitoring in a context of a 
distributed model of care (interaction of hospital and 
external teams), where it is applied to prevent 
hospitalisation of chronic disease patients. Potential 
benefits of distant monitoring must also derive from a 
global approach, where different conditions are not 
treated in isolation, but on a holistic basis. 
The trial shall be randomised. Candidates to be included 
are patients admitted to the hospital due to an 
exacerbation of their chronic condition. They will be 
stratified according to fragility criteria (e.g. severity of 
disease, social support). Sample size will be 40 patients 
(20 in the intervention group, 20 in the control group. 
The follow-up period will be 6 months. Coordination of 
interventions across the healthcare system will always 
be done through the hospital control center. Primary 
endpoints are: relapses requiring hospital admissions 
during the follow-up period, relapses requiring new 
visits to the emergency room during the follow-up and 
mortality. Secondary endpoints are: improvement in 
patients’ quality-of-life, patients’ satisfaction with the 
program, patients’ functional performance, patients’ 
adherence to the treatment, cost analysis and usability 
and user satisfaction. 
A second scenario deals with “Support after early 
discharge”: here, those chronically ill patients are 
looked at, where there are potential clinical benefits 
derived from short-lasting, intensive monitoring of vital 
signs. Those patients leave the hospital under the so-
called “early discharge and home hospitalistation 
programs”. These programs were created to partly 
mitigate the impact of high admission rates in 
exacerbated chronic patients during the winter season. 
At the same time, they provide a better recovery 
environment for the patient. To move a patient from 
conventional hospitalisation to early discharge and 
home hospitalisation programs, requires first ensuring 
clinical safety. Health professionals must be confident 
that the patients’ condition is under control. Though 
mobile teams can perform regular daily follow-ups, 
reliable and easy-to-use home monitoring will mean an 
added value. Study design, intervention structure and 
endpoints shall be the same as in the first scenario 
described above, only the follow-up period will be 
shorter here and only last 6 weeks. 
A third scenario is the “Monitoring of home 
ventilation”: end-stage chronic respiratory patients may 
require non-invasive home ventilation support, because 
of the existence of hypercapnic respiratory failure. 
These patients are more fragile and thus more 
demanding in terms of supervision by health 
professionals. The risk of exacerbation is further 
aggravated because of the existence of co-morbid 
conditions. Home monitoring should be a tool to assess 
the efficacy of non-invasive home ventilation, to allow 
detection of abnormal patient-ventilator interactions and 
allow a remote adjustment of the ventilator setting and 
to prevent exacerbation in these fragile patients. The 
trial shall be randomised. Candidates to be included are 
chronic respiratory patients admitted to hospital for 
exacerbation of their chronic respiratory condition. 
Sample size will be 10 patients (5 in the intervention 
group and 5 in the control group). The follow-up period 
will be 6 weeks. Study endpoints shall be the same as in 
the first and second scenarios described above. 
A further central point of the MobiHealth project is the 
assessment and evaluation of the trials. The trial results 
will be validated from four points of view. First, the 
accuracy and validity of the measurements taken by the 
MobiHealth BAN will be validated. This will be done 
by comparing MobiHealth measurements with those 
measurements captured using current methods. 
Secondly, the usability and suitability of the 
GPRS/UMTS networks to support the MobiHealth 
application requirements will be tested. For this, 
network-related events like change of operator or 
UMTS-GPRS hand-over will be registered and the 
effects on the MobiHealth services will be measured 
(delays, loss of data, bandwidth problems, security 
issues, etc.). Thirdly, the business and market potential 
for the new services will be defined. Related costs will 
be measured and compared with actual traditional 
methods. Subjective opinions of users and organizations 
regarding the new services, their usefulness and 
usability will be collected. This will allow to draw up a 
business case regarding the potential and profits that a 
company can expect from this type of services. The 
fourth and last issue here concerns emerging ethical 
questions. Evaluation will include the effects of 
prevention and the intervention on the person or the 
family. The different experiences of using new 
techniques, feelings of dependence or independence, the 
empowerment to influence disease-related decisions, all 
these issues will be explored across all types of trials by 
means of qualitative interviews and research. 
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 IV. CONCLUSION 
 
MobiHealth represents the convergence of different 
technologies to enable personalized, mobile health 
services. On the one hand, wearable devices for 
communication, vital constants measurement and even 
fitness applications are today commercially available at 
low prices. We can find in the market watches and belts 
to measure pulse, blood pressure and temperature, 
wearable devices for non-intrusive measurement of 
blood glucose and even wearable muscle triggering 
devices for passive fitness exercise. On the other hand, 
the notion and concepts of Body Area Networks are 
under development, targeting the problem of relaying 
signals from the multitude of wearable devices. The 
function of a BAN is to integrate all the wearable 
devices such as PDA’s mobile phones and watches that 
a person carries around during the day. Furthermore, 
GPRS networks are available today in most European 
countries and provide a globally accessible and easy-to-
use communication platform. The innovation of 
MobiHealth lies in one part in the integration of these 
three technologies in a flexible and generic system – the 
MobiHealth BAN – with the development of the 
required software that will provide an open platform for 
the creation of new, personalized services in the area of 
mobile health, and in the other part, in the introduction 
of a complete and integrated service platform that can 
be taken up by any Small/Medium Size Enterprise 
(SME) or service provider wishing to start up a new m-
health related service. 
The second part of the MobiHealth innovation lies in 
the actual services that are proposed. Today, out of 
hospital monitoring of the patients’ health state is 
practically non-existent. The patient has either to 
measure different vital constants at regular intervals or 
has to visit the hospital. As a result, patients who need 
monitoring but are not at immediate risk, are obliged to 
stay for long periods in hospital so that regular 
measurements can be taken. This results in high costs 
for the hospitals and social insurances and in the loss of 
work hours and morale of the patient [13]. MobiHealth 
proposes new services that will allow the monitoring of 
vital constants for out of hospital patients. Moreover, 
MobiHealth improves current practice by allowing 
continuous monitoring of constants such as pulse rate, 
temperature, etc, whereas today, these measurements 
are sampled at intervals only. With continuous 
monitoring, the treating doctor will have more (and 
more timely) information on the patients’ condition and 
will be able to provide better advice and suggest better 
treatment. 
Finally, MobiHealth innovates by proposing and trialing 
other new services that can be implemented by SME’s 
based on existing technologies. The MobiHealth BAN, 
being generic, can be easily customized to provide 
services to the sports community, the medical research 
community, to the study of causes and triggers in 
chronic diseases (e.g. asthma or epilepsy) and to the 
detection and prevention of serious acute events (e.g. 
sudden infant death, stroke, etc.). 
GPRS networks are available in most European 
countries and different operators are setting up UMTS 
test sites. A study made by Ericsson Consulting 
indicates enormous market and business potential for 
new health services based on wireless communications. 
Studies for Germany, United Kingdom and France show 
that the number of individuals suffering from common 
chronic diseases (diabetes, asthma, stroke, hypertension 
and coronary artery disease) exceeds 50 million. 
Finally, it is considered to be important to also point out 
to the technological and medical risks of MobiHealth. 
Technological risks include e.g. radio interference or 
interference with medical equipment. Medical risks may 
be possible health effects that the new technology might 
introduce to the patients, e.g. possible electromagnetic 
hazards associated with cell phone usage. The in-depth 
study of these risks is out of the scope of the project, 
nevertheless, risks will be identified and the project will 
take into consideration possible consequences and 
integrate existing solutions to cope with the related 
issues. 
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